Join international speaker, Professor Subrata Ghosh, Australian IBD expert, Professor Michael Kamm, and Australian dermatologist, Dr Jason Wu, at AGW 2017 as they share their insights and thoughts on the use of STELARA for Crohn’s disease.

Click here to access the Research Review Speaker Series to find out more about Ustekinumab (STELARA) - A New Option for the Treatment of Crohn’s Disease.

 

PBS Information: Authority required.
Refer to PBS Schedule for full authority information.

 

Please refer to the Product Information before prescribing. The Product Information can be accessed here.

Janssen Cilag Pty Ltd, ABN 47 000 129 975. 1-5 Khartoum Road, Macquarie Park NSW 2113. Phone: 1800 226 334. ©Janssen-Cilag Pty Ltd 2018. Trademarks and brand names are the property of Johnson & Johnson, its affiliates or third party owners.

Date of preparation: January 2018.

Panel discussion: CP-02996  |  Presentation: Ghosh Characteristics: 02994; Ghosh Data: CP-02993;  Wu: CP-02995

Disclaimer:
Views and opinions expressed in this presentation are those of the speakers alone, and do not necessarily reflect the views and opinions of Janssen-Cilag Pty Ltd (Janssen) or any employee thereof. This information is not medical advice and no decision relating to the management of any patient should be made with reliance on the information contained in this presentation.It is your responsibility to prescribe appropriate treatments in accordance with your clinical judgment and by reference to the appropriate Australian Product Information or other information supplied with the relevant product, including in relation to any indication, dosage, route of administration.

CMI | GASTROCENTRAL